BlackRock Advisors’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.57M | Buy |
381,089
+76,637
| +25% | +$317K | ﹤0.01% | 1576 |
|
|
2016
Q3 | $2.47M | Buy |
304,452
+120,616
| +66% | +$977K | ﹤0.01% | 1339 |
|
|
2016
Q2 | $1.43M | Buy |
183,836
+79,439
| +76% | +$620K | ﹤0.01% | 1570 |
|
|
2016
Q1 | $806K | Buy |
104,397
+10,320
| +11% | +$79.7K | ﹤0.01% | 1804 |
|
|
2015
Q4 | $1.02M | Buy |
94,077
+8,707
| +10% | +$93.9K | ﹤0.01% | 1675 |
|
|
2015
Q3 | $590K | Sell |
85,370
-11,847
| -12% | -$81.9K | ﹤0.01% | 2050 |
|
|
2015
Q2 | $861K | Buy |
97,217
+28,102
| +41% | +$249K | ﹤0.01% | 1739 |
|
|
2015
Q1 | $681K | Buy |
69,115
+17,236
| +33% | +$170K | ﹤0.01% | 1809 |
|
|
2014
Q4 | $636K | Sell |
51,879
-180,709
| -78% | -$2.22M | ﹤0.01% | 1785 |
|
|
2014
Q3 | $2.32M | Buy |
232,588
+100,955
| +77% | +$1.01M | ﹤0.01% | 1109 |
|
|
2014
Q2 | $996K | Sell |
131,633
-272,574
| -67% | -$2.06M | ﹤0.01% | 1471 |
|
|
2014
Q1 | $1.33M | Sell |
404,207
-231,327
| -36% | -$761K | ﹤0.01% | 1337 |
|
|
2013
Q4 | $2.11M | Sell |
635,534
-65,143
| -9% | -$216K | ﹤0.01% | 1144 |
|
|
2013
Q3 | $2.12M | Sell |
700,677
-477,470
| -41% | -$1.44M | ﹤0.01% | 1137 |
|
|
2013
Q2 | $9.64M | Buy |
+1,178,147
| New | +$9.64M | 0.01% | 789 |
|